What You Should Know:
- Capstan Medical, a medical technology company developing innovative solutions for heart valve disease secures $110M in a Series C funding round led by Eclipse with participation from existing investors Yu Galaxy and Intuitive Ventures, and new investment from Gideon Strategic Partners.
- Capstan Medical is developing a suite of next-generation heart valve implants and a first-of-its-kind catheter-based robotic delivery platform.
Addressing the Global Burden
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
Nucs AI Secures $3.5M to Advance AI-Powered Prostate Cancer Diagnostics
What You Should Know:
- Nucs AI, a company that uses AI in precision medicine for the diagnosis and treatment of prostate cancer, today announces that it has closed a $3.5 million seed round of funding.
- The company will use the funding to further build out its platform and to support FDA clearance for its technology in the United States.
Nucs AI: Transforming Prostate Cancer Diagnosis and Treatment with Precision Medicine
Founded in 2023, Nucs AI is pioneering advancements in
Read More
H1 and CTI Partner for Clinical Trial Optimization
What You Should Know:
- H1, on a mission to connect the world to the right doctors, today announced a strategic partnership with CTI Clinical Trial & Consulting Services (CTI), a leading global full-spectrum research service provider.
- Through this partnership, CTI will leverage H1’s Trial Landscape platform to drive data-informed clinical trial planning and execution to enhance strategic feasibility, real-world evidence, and clinical trial execution on a global scale. This
Read More
Carta Healthcare Acquires Realyze Intelligence to Enhance AI-Powered Clinical Trial Matching
What You Should Know:
- Carta Healthcare®, which ignites healthcare improvement by unlocking the power of clinical data, expanded the strength and capabilities of its AI-powered platform with the acquisition of Realyze Intelligence.
- The Realyze Intelligence solution leverages AI to match patients to clinical trials to accelerate research and reduce costs while providing patients with the latest advances in care.
Carta Healthcare and Realyze Intelligence:
Read More
Certis Oncology Launches AI-Powered Chatbot for Cancer Research
What You Should Know:
- Certis Oncology Solutions, a translational science and emerging technology leader in preclinical oncology research, is pleased to announce the commercial launch of CertisOI Assistant™, an innovative chatbot tool designed to enhance the efficiency and effectiveness of cancer research.
- This cutting-edge research tool leverages artificial intelligence/machine learning (AI/ML) and OpenAI’s ChatGPT language model to provide researchers unparalleled insights
Read More
How Pharma Can Enhance Infusion Clinic Operations and Patient Care
Infusion Clinics (ICs) face a delicate balancing act. They must strive for operational excellence while simultaneously navigating the realities of competition, patient care challenges, and compliance requirements. It’s a difficult challenge, and as ICs adapt to evolving demands, there’s a growing need for pharmaceutical manufacturers to step up with tailored support.
From streamlining medication access to advocating for policy changes, manufacturers can significantly impact how ICs
Read More
ConcertAI & NeoGenomics Launch CTO-H for Hematology Research
What You Should Know:
- ConcertAI and NeoGenomics (NASDAQ: NEO) announce a joint software-as-a-service solution in hematological malignancies for research analytics, clinical trial design, and clinical trial operational optimization.
- CTO-H provides a research data solution that is unprecedented in its scale, longitudinality and biomarker depth. CTO-H is a major outcome of the collaboration jointly announced on Jan. 8, 2024, and the more recent joint research completed and scheduled for
Read More
Function Health and GRAIL Collaborate to Make Multi-Cancer Early Detection Test More Accessible
What You Should Know:
- Function Health, a revolutionary health management platform empowering people to live 100 healthy years, announces a collaboration with GRAIL, Inc., a healthcare company whose mission is to detect cancer early when it can be cured, to expand the reach of innovative cancer screening to transform cancer care.
- Function Health’s 400,000+ members nationwide have access to GRAIL’s Galleri test—a first-of-its-kind, clinically validated multi-cancer early detection
Read More
Neoplas Med Secures $18M Investment to Advance Cold Plasma Wound Care Tech
What You Should Know:
- Neoplas Med GmbH, a Greifswald-based medical technology company, has secured an $18M investment from Niterra Ventures Company to further develop and expand its innovative cold plasma wound care technology.
- The latest investment brings Niterra's total investment in Neoplas Med to $25M, following previous funding rounds in 2022 and 2023.
Transforming Wound Care with Cold Plasma
Neoplas Med is a pioneer in the field of cold plasma technology for
Read More
Optimizing Clinical Trials with AI and Data-Driven Insights
While most technology- and innovation-oriented industries have followed the general principles of Moore’s Law, which holds that computing power would double yearly, while costs were cut in half, the life sciences industry appears to be spending more money developing fewer drugs.
According to the latest data, the cost to take a drug candidate from the discovery stage, all the way to market launch, hit $2.3 billion in 2022—a $298 million rise from 2021. Meanwhile, there were
Read More
